3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A1 PRE-CLINICAL CROHN’S DISEASE MICROBIOME PROMOTES INFLAMMATION IN GNOTOBIOTIC RECIPIENT MICE

      abstract

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Crohn’s disease (CD) is a chronic disorder of unknow etiology. We recently demonstrated that microbiome composition is associated with the risk of CD development; however, its potential causal effect remains unknown.

          Aims

          Given the fact that first-degree relatives (FDRs) that are sibling likely to share similar environmental and genetic makeup, we selected pairs of discordant siblings (one remaining healthy referred to as healthy matched control-HMC, and the other who developed CD later on referred to as pre-CD) to investigate whether the microbiome contributes to or triggers dysregulated immune response by transplanting microbiome from them into germ-free mice (GFM).

          Methods

          Faecal samples from discordant siblings, recruited as part of the CCC-GEM project, a cohort of prospectively followed healthy first-degree relatives, were transplanted into RAG1 -/- GFM before T-cell transfer-induced colitis. Fecal Lipocalin-2 (LCN-2) was measured by ELISA to assess gut inflammation. Body weight was monitored for 6 weeks after T-cell transfer. Intestinal tissue damage was assessed by histology scoring (PMID: 8623920). Pro-inflammatory cytokine gene profile of ileum and colon tissue was measured by qPCR. R-software was used for statistical analysis.

          Results

          Our results showed that mouse recipients of pre-CD microbiota experienced more weight loss than HMC group, with a greater difference observed in the second week after inducing colitis (p=0.0019). LCN-2 of pre-CD mice was significantly higher after T-cell transfer for 3 weeks. Intriguingly, pre-CD stool recipient mice had higher histological damage score in the ileum (p=0.025). Histological analysis revealed that granulomatous inflammation, mucin depletion, crypt loss were greater in pre-CD group (p≤0.05). Pre-CD stool promoted the expression of selected pro-inflammatory cytokine genes in the ileum with significant increases of TNFα, IL-1β, IFNγ, IL10 and TGFβ compared to mice that received HMC microbiome. Colonic tissue showed significant increases in TNFα and TGFβ in the mice recipient of the pre-CD microbiome.

          Conclusions

          These results suggests that pre-CD microbiome can worsen T cell transfer colitis in mice compared to HMC microbiome. This suggests that microbiome or other constituents of stool from pre-CD subjects are major contributors to the onset of disease. Modulating pre-CD microbiome composition could lead to novel methods to prevent CD onset.

          Funding Agencies

          CCC, CIHRWeston Family Foundation, Helmsley, Biocodex

          Related collections

          Author and article information

          Contributors
          Journal
          J Can Assoc Gastroenterol
          J Can Assoc Gastroenterol
          jcag
          Journal of the Canadian Association of Gastroenterology
          Oxford University Press (US )
          2515-2084
          2515-2092
          March 2024
          14 February 2024
          14 February 2024
          : 7
          : Suppl 1 , Abstracts Accepted to 2024 CDDW™
          : 1
          Affiliations
          Department of Medicine, University of Toronto , Toronto, ON, Canada
          Icahn School of Medicine at Mount Sinai , New York, NY
          Department of Medicine, University of Toronto , Toronto, ON, Canada
          Lunenfeld-Tanenbaum Research Institute , Toronto, ON, Canada
          Department of Medicine, University of Toronto , Toronto, ON, Canada
          Lunenfeld-Tanenbaum Research Institute , Toronto, ON, Canada
          Lunenfeld-Tanenbaum Research Institute , Toronto, ON, Canada
          Icahn School of Medicine at Mount Sinai , New York, NY
          Unity Health Toronto , Toronto, ON, Canada
          Lunenfeld-Tanenbaum Research Institute , Toronto, ON, Canada
          Icahn School of Medicine at Mount Sinai , New York, NY
          Lunenfeld-Tanenbaum Research Institute , Toronto, ON, Canada
          Department of Medicine, University of Toronto , Toronto, ON, Canada
          Article
          gwad061.001
          10.1093/jcag/gwad061.001
          10872193
          dcb33a48-8073-4ebb-bb59-6132cc726f1f
          ڣ The Author(s) 2024. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology.

          This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

          History
          Page count
          Pages: 1
          Categories
          Oral Presentations
          CAG Postdoctoral Prize
          AcademicSubjects/MED00260

          Comments

          Comment on this article